BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Witman Tsur S, Adrian Zaher E, Tsur M, Kania K, Kalinowska-Łyszczarz A. Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All? Int J Mol Sci 2021;22:3859. [PMID: 33917860 DOI: 10.3390/ijms22083859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lucchini M, Del Giacomo P, De Arcangelis V, Nociti V, Bianco A, De Fino C, Presicce G, Cicia A, Carlomagno V, Mirabella M. The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre. JPM 2022;12:591. [DOI: 10.3390/jpm12040591] [Reference Citation Analysis]
2 Alonso R, Chertcoff A, Leguizamón FDV, Galleguillos Goiry L, Eizaguirre MB, Rodríguez R, Sosa M, Carballido S, Cruchet V, de Jong-Martis A, Giachello S, Henestroza P, Ferrandina F, Bauer J, Carrá A, Silva BA. Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America. Mult Scler J Exp Transl Clin 2021;7:20552173211061543. [PMID: 34868630 DOI: 10.1177/20552173211061543] [Reference Citation Analysis]
3 Kavosh A, Ashtari F, Naghavi S, Adibi I, Shaygannejad V, Karimi Z, Arabi S, Rahimi M, Mazaheri S. Safety of Sinopharm vaccine for people with Multiple Sclerosis: Study of adverse reactions and disease activity. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103708] [Reference Citation Analysis]
4 Rutovic S, Volevach E, Maršálková H, Fumagalli AI, Corea F. What the Aftermath of the Global Pandemic Will Mean for Neurologists. Neurol Int 2021;13:297-303. [PMID: 34287348 DOI: 10.3390/neurolint13030030] [Reference Citation Analysis]
5 Türkoğlu R, Baliç N, Kızılay T, Erol R, Akbayır E, Yılmaz V, Tüzün E. Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis. Mult Scler Relat Disord 2022;58:103524. [PMID: 35033838 DOI: 10.1016/j.msard.2022.103524] [Reference Citation Analysis]